1.Diekema, DJ, et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. Journal of Clinical Microbiology 2003; 41: 3655–3660.
2.Bearman, GM, Wenzel, RP. Bacteremias: a leading cause of death. Archives of Medical Research 2005; 36: 646–659.
3.Pedersen, G, Schonheyder, HC, Sorensen, HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia – a Danish population-based cohort study from 1992 to 1997. Clinical Microbiology and Infection 2003; 9: 793–802.
4.Madsen, KM, et al. Secular trends in incidence and mortality of bacteraemia in a Danish county 1981–1994. Acta Pathologica, Microbiologica, et Immunologica Sandinavica 1999; 107: 346–352.
5.Laupland, KB, et al. Burden of community-onset bloodstream infection: a population-based assessment. Epidemiology and Infection 2007; 135: 1037–1042.
6.Uslan, DZ, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Archives of Internal Medicine 2007; 167: 834–839.
7.Douglas, MW, et al. Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study. Tropical Medicine and International Health 2004; 9: 795–804.
8.Laupland, KB, Church, DL, Gregson, DB. Blood cultures in ambulatory outpatients. BMC Infectious Diseases 2005; 5: 35.
9.Okamoto, VN, Rubenfeld, GD. Attending to the lightness of numbers: toward the understanding of critical care epidemiology. Critical Care 2004; 8: 422–424.
10.Nimri, LF, Batchoun, R. Community-acquired bacteraemia in a rural area: predominant bacterial species and antibiotic resistance. Journal of Medical Microbiology 2004; 53: 1045–1049.
11.Jackson, LA, et al. Burden of community-onset Escherichia coli bacteremia in seniors. Journal of Infectious Diseases 2005; 191: 1523–1529.
12.Morin, CA, Hadler, JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. Journal of Infectious Diseases 2001; 184: 1029–1034.
13.Sofair, AN, et al. Epidemiology of community-onset candidemia in Connecticut and Maryland. Clinical Infectious Diseases 2006; 43: 32–39.
14.Leal, J, et al. Development of a novel electronic surveillance system for monitoring of bloodstream infections. Infection Control and Hospital Epidemiology 2010; 31: 740–747.
15.Laupland, KB, et al. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000; 105: E60.
16.Laupland, KB, et al. Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative. BMC Research Notes 2009; 2: 146.
17.Laupland, KB, et al. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clinical Microbiology and Infection 2008; 14: 1041–1047.
18.Kennedy, KJ, Roberts, JL, Collignon, PJ. Escherichia coli bacteraemia in Canberra: incidence and clinical features. Medical Journal of Australia 2008; 188: 209–213.
19.Al-Hasan, MN, et al. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998–2007. Journal of Antimicrobial Chemotherapy 2009; 64: 169–174.
20.El Atrouni, WI, et al. Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study. Clinical Infectious Diseases 2009; 49: e130–138.
21.Jacobsson, G, et al. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scandinavian Journal of Infectious Diseases 2007; 39: 6–13.
22.Kyaw, MH, et al. Incidence of invasive pneumococcal disease in Scotland, 1988–99. Epidemiology and Infection 2002; 128: 139–147.
23.Hogg, GG, Strachan, JE, Lester, RA. Invasive pneumococcal disease in the population of Victoria. Medical Journal of Australia 2000; 173 (Suppl.): S32–35.
24.Campbell, JF, et al. Pneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project. Hawaii Medical Journal 1989; 48: 513–518.
25.Robinson, KA, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: Opportunities for prevention in the conjugate vaccine era. Journal of the American Medical Association 2001; 285: 1729–1735.
26.Hicks, LA, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. Journal of Infectious Diseases 2007; 196: 1346–1354.
27.Steckelberg, JM, et al. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. American Journal of Medicine 1990; 88: 582–588.
28.Friedman, ND, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Annals of Internal Medicine 2002; 137: 791–797.